<?xml version="1.0" encoding="UTF-8"?>
<p id="p0390">A qualified donor must be selected based on a confirmed history of COVID-19 infection, including a negative follow-up molecular test, the absence of symptoms, normal physical examination, and pre-donation screening assays. It should be mentioned that since plasma with a high neutralizing antibody titer is only obtained at 14 days after the resolution of symptoms, this is the best time to harvest the plasma 
 <xref rid="b0715" ref-type="bibr">[143]</xref>. Besides, it has been suggested that apheresis might be better for optimizing the convalescent plasma product, rather than whole blood donation. The appropriate dose convalescent plasma therapy in COVID-19 was determined based on past experience of applying plasma therapy in SARS-CoV, which was 5 mL/kg of plasma with ≥ 1:160 titer 
 <xref rid="b0700" ref-type="bibr">[140]</xref>.
</p>
